Noteworthy - Pharmaceutical Executive



Managing High-Priced, U.S. Biotech Rxs in Canada

July 30, 2014

As the "Sovaldi Saga" unfolds in the U.S., it's clear the situation will only deteriorate. But north of the border, it's striking how Canadian healthcare entities are managing a similar Sovaldi situation, writes Tom Norton.

Fools Rush In: The Importance of Pre-Acquisition Due Diligence

July 29, 2014

Long before a deal is signed in ink, a company's compliance and legal team should be involved in the vetting process, writes Severin Wirz.

Pharm Exec Global Digest: FDA & Social Media Special

July 25, 2014

Will the FDA's social media guidelines help your digital strategy to take off? Check out what they say — and what they mean— in the latest issue of Pharm Exec Global Digest

Pre-emption and States' Rights

July 23, 2014

Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace. Jill Wechsler reports.

Breaking Point? The Escalating Costs of Oncology Care in the US

July 17, 2014

The US healthcare system will spend more than $150 billion on cancer by 2020. Daniele Severi Bruni, Jacob Schutz, and Anthony Hewitt ask if we have we have hit a breaking point in the escalating cost of oncology care.

Fixing the Disconnect in Medical Technology

July 16, 2014

The med-tech industry has a legacy of creating life-extending products while rewarding investors. This connection between innovation and profitability has been a key driver. But, writes Doug Mowen, change is underway.

Pharm Exec's 2014 Dealmakers Outlook

July 10, 2014

As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead for M&A, licensing, and partnership activity.

WebMD: The Patient Value Equation

July 10, 2014

WebMD CEO David Schlanger tells PharmExec how connecting patients with physicians through a robust digital platform can deliver quality of care, cost savings, and better health outcomes.

Vaccines: Fire in the Cold Chain

July 10, 2014

Its only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance.


Click here